Manufactured by Eli Lilly
FDA-approved for type 2 diabetes only. Weekly injection, same active ingredient as Zepbound.
See Mounjaro savings and coverage →FDA-approved for chronic weight management and obstructive sleep apnea. Weekly injection.
See Zepbound savings and coverage →FDA Status
FDA Approved
Route
injection
Approved Indications
Typical Dose Range
2.5mg - 15mg weekly
Dosing is determined by your prescribing provider based on your individual needs. Most GLP-1 medications follow a gradual titration schedule, starting at a low dose and increasing over several weeks to reduce side effects.
Branded (Retail)
$1,100/mo
Savings Program
$299/mo
Prices are estimates and may vary by pharmacy, location, and insurance coverage. Contact your provider for accurate pricing.
This is not a complete list of side effects. Talk to your healthcare provider about what to expect and when to seek medical attention.
This site is for educational purposes only and is not medical advice. Always consult a healthcare provider before starting any medication. Full disclaimer
Zepbound is tirzepatide prescribed for weight loss. See our full pillar covering every coupon, cost breakdown, and access path.
FDA approves Zepbound (tirzepatide) for MASH with breakthrough therapy designation, marking the second GLP-1 drug approved for severe fatty liver disease affecting 6-8 million Americans.
The DoseFDA proposes excluding semaglutide, tirzepatide, and liraglutide from 503B bulk list, effectively ending large-scale compounding that provided $150-300 monthly alternatives.
MedicationsThere is no official Wegovy to Zepbound dose conversion. SURMOUNT-5 confirmed the drugs are different molecules with different titration schedules. The conservative pattern: restart at Zepbound 2.5mg and titrate from scratch.
MedicationsZepbound became the first GLP-1 the FDA approved for moderate-to-severe sleep apnea in December 2024. The distinction matters for insurance coverage but it does not mean throwing out your CPAP.
